Author:
Watts Kimberly Danieli,Layne Benjamin,Harris Ann,McColley Susanna A.
Reference9 articles.
1. Baker, M. W., Groose, M., Hoffman, G., Rock, M., Levy, H., & Farrell, P. M. (2011). Optimal DNA tier for the IRT/DNA algorithm determined by CFTR mutation results over 14 years of newborn screening. [Research Support, N.I.H., Extramural.
2. Comeau, A. M., Parad, R. B., Dorkin, H. L., Dovey, M., Gerstle, R., Haver, K., et al. (2004). Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics, 113(6), 1573–1581.
3. Giusti, R., Badgwell, A., Iglesias, A. D., & New York State Cystic Fibrosis Newborn Screening, C. (2007). New York State cystic fibrosis consortium: the first 2.5 years of experience with cystic fibrosis newborn screening in an ethnically diverse population. Pediatrics, 119(2), e460–e467.
4. Humes, K., Jones, N., & Ramirez, R. (2011). Overview of Race and Hispanic Origin: 2010.
5. O'Connor, G. T., Quinton, H. B., Kahn, R., Robichaud, P., Maddock, J., Lever, T., et al. (2002). Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatric Pulmonology, 33(2), 99–105.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献